NasdaqGS - Nasdaq Real Time Price
USD
Arbutus Biopharma Corporation (ABUS)
3.6550
-0.0150
(-0.41%)
At close: November 6 at 4:00:01 PM EST
3.6500
-0.0050
(-0.14%)
After hours: November 6 at 4:50:29 PM EST
Trade ABUS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ANDROSKI LINDSAY J.D. Chief Executive Officer |
Conversion of Exercise of derivative security | Sep 18, 2026 | 72,337 |
| BEARDSLEY ROBERT A Director |
Conversion of Exercise of derivative security | Sep 18, 2026 | 32,276 |
| HASTINGS DAVID C Chief Financial Officer |
Stock Award(Grant) | Feb 14, 2025 | 249,824 |
| NAFTZGER J CHRISTOPHER General Counsel |
Stock Award(Grant) | Feb 14, 2025 | 140,544 |
| NGUYEN TUAN Chief Financial Officer |
Conversion of Exercise of derivative security | Sep 18, 2026 | 159,963 |
| SAWHNEY ROGER M.D. Director |
Conversion of Exercise of derivative security | Sep 18, 2026 | 30,825 |
| SIMS KAREN Officer |
Stock Award(Grant) | Feb 14, 2025 | 155,494 |
